跳至主要内容
临床试验/CTRI/2020/10/028193
CTRI/2020/10/028193暂停不适用

An Open label, Clinical Study to Evaluate the Safety and efficacy of HSBP-121901 in babies of 0 – 36 months of age

The Himalaya Drug Company1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年10月10日最近更新:

试验速览

阶段
不适用
状态
暂停
入组人数
40
试验地点
1
主要终点
1. Mildness gentleness and irritation as assessed by

研究概览

简要总结

This is an Open-Label, Clinical Study to Evaluate the Safety and efficacy of HSBP-121901 in babies if 0 – 36 months of age.

As the newborn skin easily become dry and the skin very vulnerable to infections. HSBP- 121901 have many advantages like being hygienic for the infant’s skin, reducing rashes and irritations and also preventing infections caused by diapers. This study evaluates the benefits of baby diaper pants in terms of mildness, gentleness and non-irritability on baby’s skin and also the prevention of diaper rashes, less frequent change of diapers, Withstand multiple wettings, overnight use, Undisturbed, restful sleep for the baby; Less crying, less cranky after waking up, Provides soft and tender care with less friction of the diaper, No incidence of leakage of urine or faeces, Ease of diaper application and removal.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
0.00 Day(s) 至 36.00 Month(s)(—)
性别
All

入选标准

  • Babies in the age group of 0 to 36 months (inclusive of both genders)
  • Babies in general good health as determined from recent medical history and the Pediatrician.
  • Baby’s mother/legal representative, preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up.
  • Baby’s mother/legal representative, preferably mother willing to abide by and comply with the study protocol.
  • 5.Babies should not participate in any other clinical study during participation in the current study.
  • Babies delivered after complete gestation (> 38 weeks).

排除标准

  • Babies with a known history or present condition of allergic response to any other Diapers, toiletries or its components or ingredients as in the test product.
  • Babies with diarrhea/ bowel incontinence
  • Babies with diaper rashes or any allergies in the diaper area.
  • Any pre-existing systemic disease necessitating long term medications and other dermatological problems.
  • Babies requiring incubators/ ventilators or C-PAP.
  • Babies who have participated in a similar clinical investigation in the past four weeks.

结局指标

主要结局

1. Mildness gentleness and irritation as assessed by

时间窗: Day 1 (Baseline) and Day 8

pediatrician assessment Scoring

时间窗: Day 1 (Baseline) and Day 8

2. subjective questionnaire for - helps to prevent diaper rash

时间窗: Day 1 (Baseline) and Day 8

less frequent change of diapers Withstand

时间窗: Day 1 (Baseline) and Day 8

multiple wetting

时间窗: Day 1 (Baseline) and Day 8

overnight use Undisturbed restful

时间窗: Day 1 (Baseline) and Day 8

sleep for the baby

时间窗: Day 1 (Baseline) and Day 8

Less crying

时间窗: Day 1 (Baseline) and Day 8

less cranky after

时间窗: Day 1 (Baseline) and Day 8

waking up

时间窗: Day 1 (Baseline) and Day 8

Provides soft and tender care with less

时间窗: Day 1 (Baseline) and Day 8

friction of the diaper

时间窗: Day 1 (Baseline) and Day 8

No incidence of leakage of

时间窗: Day 1 (Baseline) and Day 8

urine or feces

时间窗: Day 1 (Baseline) and Day 8

Ease of diaper application and removal

时间窗: Day 1 (Baseline) and Day 8

overall satisfaction of the product

时间窗: Day 1 (Baseline) and Day 8

次要结局

  • 1. Local intolerance of the product assessed by(Pediatrician)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验

Safety and efficacy of baby diaper pant | 临床试验